HomeTCRX • NASDAQ
add
Tscan Therapeutics Inc
Previous close
$8.62
Day range
$8.55 - $8.81
Year range
$1.93 - $9.00
Market cap
415.82M USD
Avg Volume
252.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 7.21M | 132.99% |
Operating expense | 6.16M | 0.36% |
Net income | -19.61M | -4.75% |
Net profit margin | -271.99 | 55.04% |
Earnings per share | -0.11 | 85.90% |
EBITDA | -20.08M | -16.96% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 192.04M | 60.00% |
Total assets | 272.15M | 36.70% |
Total liabilities | 121.28M | 21.70% |
Total equity | 150.87M | — |
Shares outstanding | 47.88M | — |
Price to book | 2.74 | — |
Return on assets | -18.95% | — |
Return on capital | -21.39% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -19.61M | -4.75% |
Cash from operations | -23.77M | -48.44% |
Cash from investing | 1.91M | 238.93% |
Cash from financing | 19.00K | -82.41% |
Net change in cash | -21.83M | -26.36% |
Free cash flow | -16.06M | -30.91% |
About
Founded
2018
Headquarters
Website
Employees
154